Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2011

Sep 21, 2011

32853_dirs_2011-09-21_432b57f5-bca5-4301-a78c-4c9ebc70df30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-09-19

Reporting Person: Yow Mai Chan (VP, WW Mfg & MD-Singapore)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-19 Common Stock M 5093 $4.08 Acquired 5093.00 Direct
2011-09-19 Common Stock S 5093 $14.4204 Disposed 0.00 Direct
2011-09-19 Common Stock M 3468 $4.08 Acquired 3468.00 Direct
2011-09-19 Common Stock S 3468 $14.4204 Disposed 0.00 Direct
2011-09-19 Common Stock M 4772 $3.39 Acquired 4772.00 Direct
2011-09-19 Common Stock S 4772 $14.4204 Disposed 0.00 Direct
2011-09-19 Common Stock M 6667 $4.45 Acquired 6667.00 Direct
2011-09-19 Common Stock S 6667 $14.4204 Disposed 0.00 Direct
2011-09-20 Common Stock M 20000 $3.39 Acquired 20000.00 Direct
2011-09-20 Common Stock S 20000 $14.6172 Disposed 0.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-09-19 Employee Stock Option (Right to Buy) $4.08 M 5093 Disposed 2019-11-17 Common Stock (5093) Direct
2011-09-19 Employee Stock Option (Right to Buy) $4.08 M 3468 Disposed 2019-11-17 Common Stock (3468) Direct
2011-09-19 Employee Stock Option (Right to Buy) $3.39 M 4772 Disposed 2015-08-02 Common Stock (4772) Direct
2011-09-19 Employee Stock Option (Right to Buy) $4.45 M 6667 Disposed 2016-09-26 Common Stock (6667) Direct
2011-09-20 Employee Stock Option (Right to Buy) $3.39 M 20000 Disposed 2015-08-02 Common Stock (20000) Direct

Footnotes

F1: The sales reported by Ms. Yow were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2011.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares acquired. These shares were purchased in multiple transactions at prices ranging from $14.12 to $14.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

F3: 70% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 30% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining unvested shares subject to the Option shall vest each month thereafter.

F4: 60% of the shares subject to the Option vested on December 31, 2009 and the remaining shares shall vest on December 31, 2012.

F5: 100% of the shares subject to the Option vested on June 8, 2009.

F6: 100% of the shares subject to the Option vested on December 27, 2010.

F7: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares acquired. These shares were purchased in multiple transactions at prices ranging from $14.27 to $14.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.